Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Energy Transfer Partners
ET
|
+$560M |
| 2 |
Apple
AAPL
|
+$375M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$354M |
| 4 |
Alibaba
BABA
|
+$275M |
| 5 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$263M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.83B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$703M |
| 3 |
ETP
Energy Transfer Partners, L.P.
ETP
|
+$677M |
| 4 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$297M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$291M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.78% |
| 2 | Financials | 5.08% |
| 3 | Healthcare | 4.24% |
| 4 | Consumer Discretionary | 4.16% |
| 5 | Energy | 3.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Insmed
INSM
$22.4B
| $5M | 0.01% |
380,922
+104,989
| +38% | +$1.68M |
|
1802
Unilever
UL
$142B
| $4.99M | 0.01% |
84,838
-3,094
| -4% | -$186K |
|
|
AVP
1803
PUT
DELISTED
Avon Products, Inc.
AVP
| $4.98M | 0.01% |
3,276,900
-41,800
| -1% | -$80.1K |
|
|
DHC
1804
Diversified Healthcare Trust
DHC
$2.15B
| $4.98M | 0.01% |
424,533
+178,145
| +72% | +$2.64M |
|
|
ENLK
1805
DELISTED
EnLink Midstream Partners, LP
ENLK
| $4.98M | 0.01% |
452,024
+307,100
| +212% | +$4.53M |
|
1806
SM Energy
SM
$7.6B
| $4.96M | 0.01% |
320,244
+312,339
| +3,951% | +$7.22M |
|
1807
CALL
The Mosaic Company
MOS
$7.19B
| $4.95M | 0.01% |
169,600
+51,200
| +43% | +$1.68M |
|
1808
CALL
Tenet Healthcare
THC
$22.2B
| $4.95M | 0.01% |
288,900
+78,600
| +37% | +$1.9M |
|
1809
PUT
iShares US Transportation ETF
IYT
$2.28B
| $4.95M | 0.01% |
+120,000
| New | +$5.54M |
|
1810
CALL
Mohawk Industries
MHK
$6.91B
| $4.95M | 0.01% |
42,300
-5,900
| -12% | -$787K |
|
1811
Matador Resources
MTDR
$6.04B
| $4.95M | 0.01% |
318,562
+301,740
| +1,794% | +$7.58M |
|
|
SGMO
1812
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $4.94M | 0.01% |
430,604
+328,137
| +320% | +$4.08M |
|
1813
PUT
Fastenal
FAST
$54.8B
| $4.94M | 0.01% |
378,000
+160,000
| +73% | +$2.16M |
|
|
ICPT
1814
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $4.93M | 0.01% |
48,900
-1,200
| -2% | -$124K |
|
1815
White Mountains Insurance
WTM
$5.33B
| $4.93M | 0.01% |
5,744
-483
| -8% | -$430K |
|
1816
Enanta Pharmaceuticals
ENTA
$362M
| $4.92M | 0.01% |
69,495
+62,367
| +875% | +$4.78M |
|
1817
Neurocrine Biosciences
NBIX
$18.2B
| $4.92M | 0.01% |
68,849
+40,511
| +143% | +$3.88M |
|
1818
Abercrombie & Fitch
ANF
$4.55B
| $4.91M | 0.01% |
244,951
+98,215
| +67% | +$1.84M |
|
1819
CALL
Cummins
CMI
$83.6B
| $4.91M | 0.01% |
36,700
-3,500
| -9% | -$494K |
|
1820
CALL
Bank of Montreal
BMO
$123B
| $4.9M | 0.01% |
75,000
-2,100
| -3% | -$156K |
|
1821
Jones Lang LaSalle
JLL
$15.8B
| $4.9M | 0.01% |
38,677
+28,845
| +293% | +$3.9M |
|
1822
CALL
Perrigo
PRGO
$1.44B
| $4.89M | 0.01% |
126,300
-438,900
| -78% | -$27.9M |
|
1823
PUT
XPO
XPO
$23.4B
| $4.89M | 0.01% |
248,082
+178,110
| +255% | +$4.94M |
|
1824
EastGroup Properties
EGP
$11.2B
| $4.89M | 0.01% |
53,333
-6,211
| -10% | -$599K |
|
1825
Itaú Unibanco
ITUB
$89.8B
| $4.89M | 0.01% |
735,563
-649,105
| -47% | -$4.17M |
|
Similar funds
Citigroup's Q4 2018 Portfolio in Review
As of Q4 2018, Citigroup held 8,079 positions worth $98.7B, down 12% from $112B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Citigroup deployed $3.55B of net new capital in Q4 2018, opening 273 new positions and adding to 3,486 existing holdings. Its largest new stake was Takeda Pharmaceutical: 6,548,306 shares worth $113M.
By sector, the portfolio is most concentrated in Technology at 5.8% of assets, up from 5.1% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $1.83B trimmed.
- Citigroup's largest Q4 2018 buy was Takeda Pharmaceutical: 6,548,306 shares worth $113M.
- Citigroup added most to Energy Transfer Partners in Q4 2018, an estimated $560M increase.
- Citigroup's biggest Q4 2018 reduction was iShares Russell 2000 ETF, cutting an estimated $1.83B.
- Citigroup fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $677M.
- Citigroup's ten largest holdings make up 17% of its $98.7B portfolio in Q4 2018.
- Citigroup opened 273 new positions and closed 357 in Q4 2018.
- Citigroup's portfolio value fell 12% quarter-over-quarter to $98.7B.
Based on Citigroup's 13F filing for Q4 2018, filed 12 Feb 2019.